We are live on
!
Find out more
LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$2.63B
1-Year Est. Return
31.52%
This Fund
S&P 500
This Quarter
Est. Return
-13.16%
1 Year Est. Return
+31.52%
3 Year Est. Return
+98.77%
5 Year Est. Return
+107.98%
10 Year Est. Return
+494.97%
AUM
$1.18B
AUM Growth
-$93.5M
(-7.3%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
9.6%
Top 10 Holdings %
Top 10 Hldgs %
21.21%
Holding
341
New
184
Increased
50
Reduced
82
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$12.6M |
| 2 |
Manulife Financial
MFC
|
+$7.56M |
| 3 |
Glaukos
GKOS
|
+$7.01M |
| 4 |
Amazon
AMZN
|
+$6.67M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$6.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$11.7M |
| 2 |
UnitedHealth
UNH
|
+$11.3M |
| 3 |
iRhythm Holdings
IRTC
|
+$9.63M |
| 4 |
Halozyme
HALO
|
+$8.33M |
| 5 |
CRISPR Therapeutics
CRSP
|
+$7.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.65% |
| 2 | Financials | 13.97% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Technology | 8.36% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vertex Pharmaceuticals
VRTX
$133B
| $759K | 0.06% |
+2,694
| New | +$721K |
|
177
Cigna
CI
$73.3B
| $747K | 0.06% |
+2,836
| New | +$731K |
|
178
Walmart Inc
WMT
$923B
| $737K | 0.06% |
+18,189
| New | +$839K |
|
179
Union Pacific
UNP
$174B
| $734K | 0.06% |
+3,442
| New | +$783K |
|
180
Kinder Morgan
KMI
$70.7B
| $733K | 0.06% |
43,759
+1,614
| +4% | +$30.2K |
|
181
Cheniere Energy
LNG
$55.4B
| $732K | 0.06% |
+5,506
| New | +$750K |
|
182
Advanced Micro Devices
AMD
$788B
| $730K | 0.06% |
+9,547
| New | +$894K |
|
183
Expeditors International
EXPD
$24B
| $730K | 0.06% |
+7,493
| New | +$768K |
|
184
Oracle
ORCL
$442B
| $712K | 0.06% |
10,191
-1,253
| -11% | -$91.7K |
|
185
Texas Instruments
TXN
$253B
| $709K | 0.06% |
+4,612
| New | +$776K |
|
186
Sherwin-Williams
SHW
$87.4B
| $680K | 0.06% |
+3,035
| New | +$779K |
|
187
Enbridge
ENB
$112B
| $674K | 0.06% |
16,108
+4,785
| +42% | +$214K |
|
188
Church & Dwight Co
CHD
$24B
| $664K | 0.06% |
+7,170
| New | +$677K |
|
189
Canadian National Railway
CNI
$76.4B
| $657K | 0.06% |
+5,893
| New | +$689K |
|
190
Lam Research
LRCX
$408B
| $657K | 0.06% |
+15,410
| New | +$734K |
|
|
GOOS
191
Canada Goose Holdings
GOOS
$844M
| $630K | 0.05% |
+35,000
| New | +$739K |
|
192
Intuit
INTU
$91.6B
| $628K | 0.05% |
+1,629
| New | +$675K |
|
193
Morgan Stanley
MS
$342B
| $620K | 0.05% |
+8,146
| New | +$667K |
|
194
Goldman Sachs
GS
$302B
| $619K | 0.05% |
+2,085
| New | +$649K |
|
195
Booz Allen Hamilton
BAH
$9.43B
| $618K | 0.05% |
+6,836
| New | +$584K |
|
196
Xylem
XYL
$28.5B
| $599K | 0.05% |
+7,664
| New | +$633K |
|
197
NRG Energy
NRG
$25.4B
| $591K | 0.05% |
15,471
-6,017
| -28% | -$246K |
|
198
SLB Ltd
SLB
$78.1B
| $578K | 0.05% |
16,168
-434
| -3% | -$18.1K |
|
199
Blackrock
BLK
$180B
| $554K | 0.05% |
+909
| New | +$592K |
|
200
Baker Hughes
BKR
$63.8B
| $549K | 0.05% |
19,029
-8,889
| -32% | -$301K |
|
Similar funds
SI
WWM
ACM
CCM
MG
PCMI
PCIG
MAMU
Lombard Odier Asset Management (Switzerland)'s Q2 2022 Portfolio in Review
As of Q2 2022, Lombard Odier Asset Management (Switzerland) held 341 positions worth $1.18B, down 7.3% from $1.27B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lombard Odier Asset Management (Switzerland) deployed $113M of net new capital in Q2 2022, opening 184 new positions and adding to 50 existing holdings. Its largest new stake was Glaukos: 147,742 shares worth $6.71M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 57% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was AbbVie, an estimated $11.7M trimmed.
- Lombard Odier Asset Management (Switzerland)'s largest Q2 2022 buy was Glaukos: 147,742 shares worth $6.71M.
- Lombard Odier Asset Management (Switzerland) added most to DexCom in Q2 2022, an estimated $12.6M increase.
- Lombard Odier Asset Management (Switzerland)'s biggest Q2 2022 reduction was AbbVie, cutting an estimated $11.7M.
- Lombard Odier Asset Management (Switzerland) fully exited G1 Therapeutics, Inc. Common Stock in Q2 2022, selling an estimated $4.12M.
- Lombard Odier Asset Management (Switzerland)'s ten largest holdings make up 21% of its $1.18B portfolio in Q2 2022.
- Lombard Odier Asset Management (Switzerland) opened 184 new positions and closed 18 in Q2 2022.
- Lombard Odier Asset Management (Switzerland)'s portfolio value fell 7.3% quarter-over-quarter to $1.18B.
Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.